Goldman Sachs’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q2 | – | Sell |
-1,752,374
| Closed | -$34.1M | – | 4446 |
|
|
2018
Q1 | $34.1M | Buy |
1,752,374
+127,880
| +8% | +$2.49M | 0.01% | 1263 |
|
|
2017
Q4 | $27M | Sell |
1,624,494
-369,934
| -19% | -$6.16M | 0.01% | 1403 |
|
|
2017
Q3 | $40.5M | Buy |
1,994,428
+1,267,171
| +174% | +$25.7M | 0.01% | 1185 |
|
|
2017
Q2 | $11.7M | Buy |
727,257
+487,118
| +203% | +$7.84M | ﹤0.01% | 1848 |
|
|
2017
Q1 | $3.04M | Sell |
240,139
-105,638
| -31% | -$1.34M | ﹤0.01% | 2479 |
|
|
2016
Q4 | $4.58M | Buy |
345,777
+145,500
| +73% | +$1.93M | ﹤0.01% | 2235 |
|
|
2016
Q3 | $4.75M | Sell |
200,277
-171,033
| -46% | -$4.05M | ﹤0.01% | 2266 |
|
|
2016
Q2 | $10.7M | Buy |
371,310
+159,493
| +75% | +$4.6M | ﹤0.01% | 1717 |
|
|
2016
Q1 | $6.78M | Buy |
211,817
+103,030
| +95% | +$3.3M | ﹤0.01% | 1934 |
|
|
2015
Q4 | $4.65M | Sell |
108,787
-76,943
| -41% | -$3.29M | ﹤0.01% | 2086 |
|
|
2015
Q3 | $6.54M | Sell |
185,730
-35,008
| -16% | -$1.23M | ﹤0.01% | 1856 |
|
|
2015
Q2 | $10.1M | Sell |
220,738
-161,806
| -42% | -$7.43M | ﹤0.01% | 1687 |
|
|
2015
Q1 | $17.9M | Buy |
382,544
+174,459
| +84% | +$8.18M | 0.01% | 1362 |
|
|
2014
Q4 | $6.59M | Sell |
208,085
-23,008
| -10% | -$729K | ﹤0.01% | 1820 |
|
|
2014
Q3 | $5.48M | Sell |
231,093
-46,893
| -17% | -$1.11M | ﹤0.01% | 1926 |
|
|
2014
Q2 | $8.34M | Buy |
277,986
+77,338
| +39% | +$2.32M | ﹤0.01% | 1709 |
|
|
2014
Q1 | $5.3M | Buy |
200,648
+29,196
| +17% | +$771K | ﹤0.01% | 1942 |
|
|
2013
Q4 | $4.31M | Buy |
171,452
+143,288
| +509% | +$3.6M | ﹤0.01% | 2094 |
|
|
2013
Q3 | $577K | Sell |
28,164
-237,304
| -89% | -$4.86M | ﹤0.01% | 3253 |
|
|
2013
Q2 | $5.29M | Buy |
+265,468
| New | +$5.29M | ﹤0.01% | 1729 |
|